| Literature DB >> 19719240 |
Dario Giardinà1, Daniele Martarelli, Gianni Sagratini, Piero Angeli, Dario Ballinari, Ugo Gulini, Carlo Melchiorre, Elena Poggesi, Pierluigi Pompei.
Abstract
Doxazosin analogues 1-3 and 1a were synthesized and investigated at alpha1-adrenoceptors and PC-3, DU-145, and LNCaP human prostate cancer cells. Compound 1 (cyclodoxazosin) was a potent alpha(1B)-adrenoceptor antagonist displaying antiproliferative activity higher than that of doxazosin in cancer cells in vitro and in vivo, respectively. Because of its antitumor efficacy at low concentrations, lower apoptotic activity in NHDF vs tumor cells, and antiangiogenetic effect, 1 showed a better therapeutic profile relative to doxazosin.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19719240 DOI: 10.1021/jm8016046
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446